Eligard 7.5mg: May Not Be Filled With Correct Amount Of Leuprolide Acetate.
ELIGARD 7.5mg injectable vials distributed in Canada may contain an incorrect amount of the active ingredient leuprolide acetate. This is a Class I recall, meaning there is a potential serious adverse health consequence. The affected product was distributed across Canada.
- Product
- ELIGARD 7.5mg
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2023-09-12
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/cdb5224c-d383-4f80-b3e1-194b378681d7